Zhang, Fengmei – Trademark Portfolio

Entity Type: 01

Zhang, Fengmei holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 24 (Fabrics) — 3 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include EOLIKNS, HIBOJEC, SUDNWAO, TIROERV, and OPALNTUS. The owner is based in Licheng, Putian,Fujian.

No. 212, Chengwei, Dengying, Huangshi

Licheng, Putian,Fujian 351144 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OPALNTUS
OPALNTUS
Registered 2021
SUDNWAO
SUDNWAO
Registered 2021
EOLIKNS
EOLIKNS
Registered 2020
HIBOJEC
HIBOJEC
Registered 2020
TIROERV
TIROERV
Registered 2020

Trademark Classifications

Zhang, Fengmei's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

24
Fabrics (3 filings)

Textiles and textile goods; bed covers; table covers

25
Clothing (2 filings)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Zhang, Fengmei have?

Zhang, Fengmei has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does Zhang, Fengmei file in?

Zhang, Fengmei files trademarks across 2 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 25 (Clothing). Class 24 covers textiles and textile goods; bed covers; table covers.

What are Zhang, Fengmei's most well-known trademarks?

Zhang, Fengmei's registered trademark portfolio includes well-known marks such as EOLIKNS, HIBOJEC, SUDNWAO, TIROERV, and OPALNTUS. These are among 5 currently registered trademarks in the portfolio.

What is Zhang, Fengmei's trademark registration success rate?

Zhang, Fengmei has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.